EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:8356 - pramipexole
| Formula | C10H17N3S |
| Net Charge | 0 |
| Average Mass | 211.334 |
| Monoisotopic Mass | 211.11432 |
| SMILES | CCCN[C@H]1CCc2nc(N)sc2C1 |
| InChI | InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1 |
| InChIKey | FASDKYOPVNHBLU-ZETCQYMHSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | radical scavenger A role played by a substance that can react readily with, and thereby eliminate, radicals. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. dopamine agonist A drug that binds to and activates dopamine receptors. |
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antidyskinesia agent Any compound which can be used to treat or alleviate the symptoms of dyskinesia. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. dopamine agonist A drug that binds to and activates dopamine receptors. antiparkinson drug A drug used in the treatment of Parkinson's disease. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pramipexole (CHEBI:8356) has role analgesic (CHEBI:35480) |
| pramipexole (CHEBI:8356) has role antidepressant (CHEBI:35469) |
| pramipexole (CHEBI:8356) has role antidyskinesia agent (CHEBI:66956) |
| pramipexole (CHEBI:8356) has role antiparkinson drug (CHEBI:48407) |
| pramipexole (CHEBI:8356) has role antipsychotic agent (CHEBI:35476) |
| pramipexole (CHEBI:8356) has role dopamine agonist (CHEBI:51065) |
| pramipexole (CHEBI:8356) has role radical scavenger (CHEBI:48578) |
| pramipexole (CHEBI:8356) is a benzothiazoles (CHEBI:37947) |
| pramipexole (CHEBI:8356) is a diamine (CHEBI:23666) |
| pramipexole (CHEBI:8356) is a organic molecular entity (CHEBI:50860) |
| pramipexole (CHEBI:8356) is a thiazoles (CHEBI:48901) |
| pramipexole (CHEBI:8356) is conjugate base of pramipexole(2+) (CHEBI:63218) |
| Incoming Relation(s) |
| pramipexole(2+) (CHEBI:63218) is conjugate acid of pramipexole (CHEBI:8356) |
| IUPAC Name |
|---|
| (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine |
| INNs | Source |
|---|---|
| pramipexol | WHO MedNet |
| pramipexole | WHO MedNet |
| pramipexole | ChemIDplus |
| pramipexolum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)- | ChemIDplus |
| Ctc-501 | ChEMBL |
| NSC-760426 | ChEMBL |
| (-)-Pramipexole | ChemIDplus |
| SUD-919CL2Y | ChEMBL |
| SUD919CL2Y | ChEMBL |
| Brand Names | Source |
|---|---|
| Neliprax | ChEMBL |
| Pipexus | ChEMBL |
| Registry Numbers | Sources |
|---|---|
| Beilstein:6479326 | Beilstein |
| CAS:104632-26-0 | ChemIDplus |
| Citations |
|---|